Evidence map›Paper›PMID 39725958›Full record

ArticleBMC oral health2024

In vitro comparison of the effects of titanium-prepared platelet-rich fibrin and leukocyte platelet-rich fibrin on osteoblast behavior and their gen expression.

Melike Baygın, Aris Çakiris, Ayşegül Yabacı Tak, Neslihan Abacı, Sema Sırma Ekmekçi, Banu Gürkan Köseoğlu

Abstract readComparative Study
In one paragraph

Article in BMC oral health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Melike BaygınIstanbul University Institute of Graduate Studies in Health Sciences, Bozdoğan Kemeri Caddesi No:4 Vezneciler Hamamı Sokağı Vezneciler, Fatih/İstanbul, 34126, Turkey.
Aris ÇakirisAziz Sancar Institute Of Experimental Medicine, Department Of Genetics, Istanbul University, Vakif Gureba Cad. Sehremini, Istanbul, 34093, Turkey.
Ayşegül Yabacı TakFaculty Of Medicine, Department of Biostatistics and Medical Information, Bezmialem Vakif University, Vatan Street, Fatih/İstanbul, 34093, Turkey.
Neslihan AbacıAziz Sancar Institute Of Experimental Medicine, Department Of Genetics, Istanbul University, Vakif Gureba Cad. Sehremini, Istanbul, 34093, Turkey.
Sema Sırma EkmekçiAziz Sancar Institute Of Experimental Medicine, Department Of Genetics, Istanbul University, Vakif Gureba Cad. Sehremini, Istanbul, 34093, Turkey.
Banu Gürkan KöseoğluFaculty Of Dentistry, Department of Oral and Maxillofacial Surgery, Istanbul University, Süleymaniye, Prof. Dr. Cavit Orhan Tütengil Sk. No:4, Fatih/İstanbul, 34116, Turkey. banugr@istanbul.edu.tr.

Funding

Scientific Research Projects Coordination Unit of Istanbul University 38065
6 · The paper itself

Abstract

objectiveTo compare the effects of titanium-prepared platelet-rich fibrin (T-PRF) and leukocyte platelet-rich fibrin (L-PRF) on osteoblasts.

methodsVenous blood samples were collected from ten volunteer patients to obtain T-PRF and L-PRF. The T-PRF group was labelled as Group T, the L-PRF group as Group L, and the control group, which includes only osteoblasts, was Group K. PRF samples were added to cultured osteoblast cells and cell proliferation was assessed using an MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide) assay. The effect of different groups on osteoblast proliferation was observed for 72 h and the results were analysed statistically. Additionally, real-time polymerase chain reaction (RT-PCR) was conducted to evaluate gene expression levels of COL1A1, ALP, OCN, and RUNX2 within 48 h.

resultsWe found that the MTT results at 24 h were significantly lower than those at 48 and 72 h (p = 0.036 and p < 0.001, respectively). L-PRF levels showed an increase from 24 to 48 h followed by a decrease from 48 to 72 h. T-PRF levels were seen to increase at both the 24-48 h and 48-72-hour intervals. The changes in the COLA1, OCN, ALP, and RUNX2 genes at 24 h and 48 h did not significantly differ among the groups (p > 0.05).

conclusionsIn this study, we investigated the effects of T-PRF and L-PRF on osteoblast proliferation over a 72-hour period. Both groups improved osteoblast proliferation, however T-PRF group showed a consistent increase in osteoblast proliferation up to 72 h, in contrast to the L-PRF group. No differences in gene expression were found. However, osteoblastic marker genes can be significantly expressed over longer time periods. Therefore, long-term studies are needed.

Indexed as

Cell ProliferationCore Binding Factor Alpha 1 SubunitLeukocytesOsteoblastsPlatelet-Rich FibrinTitaniumAlkaline PhosphataseCells, CulturedCollagen Type ICollagen Type I, alpha 1 ChainGene ExpressionHumansIn Vitro TechniquesMaleOsteocalcinReal-Time Polymerase Chain ReactionAlkaline PhosphataseCollagen Type ICollagen Type I, alpha 1 ChainCore Binding Factor Alpha 1 SubunitOsteocalcinRUNX2 protein, humanTetrazolium SaltsTitaniumCell cultureLeukocyte platelet-rich fibrinOsteoblastPlatelet-rich fibrinTitanium-prepared platelet-rich fibrin

Identifiers

PMID39725958
PMCPMC11673954

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.